Therapeutic Product Immunogenicity Community

 View Only
Back to discussions
Expand all | Collapse all

Cut points -- impact of distribution, sample size, and outlier removal

  • 1.  Cut points -- impact of distribution, sample size, and outlier removal

    Community Leadership
    Posted 04-19-2023 16:10

    During the next Immunogenicity Discussion Group (May 3rd at 12pm EDT), we will hear from the authors and be discussing the recently published manuscript in AAPS Journal "Statistical Approaches for Establishing Appropriate Immunogenicity Assay Cut Points: Impact of Sample Distribution, Sample Size, and Outlier Removal".  Link to article: https://rdcu.be/dag4q.

    If you would like to participate in this discussion, please contact myself ([email protected]) or my co-lead, Rob Nelson ([email protected]).



    ------------------------------
    Todd Lester
    Director | BioAgilytix | Durham, NC
    [email protected]

    Disclaimer: Opinions expressed are solely my own and do not express the views or opinions of my employer.
    ------------------------------